Cancer

Explore the complexities of Cancer research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against cancer with flcube.com.

Shandong Lukang Wins NMPA Registration for Generic Cefuroxime Sodium for Injection – Entering a RMB 2.6 Billion Chinese Cephalosporin Market
CompanyDrug

Shandong Lukang Wins NMPA Registration for Generic Cefuroxime Sodium for Injection – Entering a RMB 2.6 Billion Chinese Cephalosporin Market

Shandong Lukang Pharmaceutical Co., Ltd. (SHA: 600789) announced that it has received Drug Registration Certificates (Certificate Nos. 2026S03571 and 2026S03572) from China's National Medical Products Administration (NMPA) for Cefuroxime Sodium…

Xunfei Healthcare Establishes Hainan Xunfei Internet Hospital Subsidiary with RMB 10 Million Registered Capital – Extending Digital Healthcare Footprint in Hainan Free Trade Port

Xunfei Healthcare Establishes Hainan Xunfei Internet Hospital Subsidiary with RMB 10 Million Registered Capital – Extending Digital Healthcare Footprint in Hainan Free Trade Port

CSPC's Recombinant Herpes Zoster Vaccine SYS6052 Clears U.S. FDA IND – Company's First Recombinant Protein Vaccine Candidate to Enter Clinical Trials

CSPC’s Recombinant Herpes Zoster Vaccine SYS6052 Clears U.S. FDA IND – Company’s First Recombinant Protein Vaccine Candidate to Enter Clinical Trials

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Simcere Completes Enrollment for Phase III Study of CDK4/6 Inhibitor in mTNBC

CompanyDrug

Hengrui Medicine’s Pyrotinib Filing Accepted for Review by NMPA

CompanyDrug

Innovent’s Cyramza Gains NMPA Approval for Hepatocellular Carcinoma

CompanyDrug

Salubris Pharmaceuticals’ First-in-Class Anti-Tumor Drug SAL008 Accepted by NMPA

CompanyDrug

Roche’s Subcutaneous Herceptin Approved in China for HER2-Positive Breast Cancer

CompanyDrug

Merck’s Keytruda Gains 9th Indication Approval in China for Hepatocellular Carcinoma

CompanyDeals

Convalife and Jointown Partner for Global Drug Development and Commercialization

CompanyDrug

Eli Lilly’s Retevmo Wins First China Approvals for RET-Driven Cancers

Show More